See every side of every news story
Published loading...Updated

Boston Scientific is ‘very bullish’ on 2025 despite $200M tariff hit

Summary by medtechdive.com
The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of dollars from President Donald Trump’s tariff policies.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

medtechdive.com broke the news in on Wednesday, April 23, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.